Viewing Study NCT06877104


Ignite Creation Date: 2025-12-24 @ 9:20 PM
Ignite Modification Date: 2025-12-30 @ 3:23 AM
Study NCT ID: NCT06877104
Status: RECRUITING
Last Update Posted: 2025-03-26
First Post: 2025-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression
Sponsor: University of Pennsylvania
Organization:

Study Overview

Official Title: Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression
Status: RECRUITING
Status Verified Date: 2025-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: HEALED
Brief Summary: The purpose of the study is to determine if access to a text-message based holistic chatbot support program "Healing at Home 2.0" decreases depressive symptoms as measured by the Edinburgh Postnatal Depression Scale (EPDS) compared to usual postpartum care for patients of color.
Detailed Description: Healing at Home (H@H) 2.0 is a comprehensive technology-based postpartum support program which provides 24/7 support to individuals through use of an SMS chatbot for six weeks postpartum. This will be a randomized controlled trial (RCT) with an intervention arm consisting of patients who are planning to be discharged at routine timing (as determined by their clinical team) with access to H@H 2.0 postpartum SMS chatbot platform and a control arm which consists of usual postpartum care.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: